Sensitivity of breast and ovarian cancer cells for interferons (IFNs) and retinoids.
Daxenbichler
G
G
Department of Obstetrics and Gynecology, University of Innsbruck, Austria.
Widschwendter
M
M
Marth
C
C
D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*; D018394:CA-125 Antigen / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D004354:Drug Screening Assays, Antitumor; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007372:Interferons / Q000494:pharmacology*; D010051:Ovarian Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D012176:Retinoids / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D007372:Interferons; D018719:Erb-b2 Receptor Tyrosine Kinases; D012176:Retinoids